Skip to main content
Clinical Trials/NCT04360369
NCT04360369CompletedNot Applicable

Comparison of Intraocular Pressure Measurements Between Reichert Tono-Vera Tonometer and Goldmann Tonometry

Reichert, Inc.1 site in 1 country61 target enrollmentStarted: October 19, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
61
Locations
1
Primary Endpoint
Demonstrate compliance with ANSI Z80.10-2014-Ophthalmics-Ophthalmic Instruments-Tonometers.

Study Overview

Brief Summary

Determine if the Tono-Vera Tonometer accurately measures intraocular pressure (IOP). The hypothesis of this test is to confirm the Tono-Vera Tonometer is equivalent to the Goldmann Applanation Tonometer (within +/- 5.0 mmHg).

Detailed Description

The Tono-Vera Tonometer (Reichert, Inc.) is a portable rebound tonometer intended to measure IOP. Subjects will undergo a standard ophthalmologic examination. Subjects will then be measured with four tonometers: Goldmann Applanation Tonometer (C.S.O. SRL), Ocular Response Analyzer G3 (Reichert, Inc.), iCare ic100 tonometer (iCare Finland Oy), and Tono-Vera Tonometer.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Sequential
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Subjects must be male or female, between the ages of 18 and 90 years old;
  • •Be able and willing to provide signed informed consent
  • •Be able to follow study instructions

Exclusion Criteria

  • •Subjects with only one functional eye;
  • •Subjects with one eye having poor or eccentric fixation;
  • •Subjects with central corneal thickness greater than 600 µm or less than 500 µm (about 2 standard deviations the human mean);
  • •Subjects with corneal scarring or who have had corneal surgery, including corneal laser surgery;
  • •Subjects with concomitant ocular diseases such as: microphthalmos, buphthalmos, nystagmus, keratoconus, severe dry eye syndrome, blepharospasm, any other corneal or conjunctival pathology or infection;
  • •Contact lens wearers;
  • •Known allergy to proparacaine or fluorescein as these are used to anesthetize the eye and allow IOP measurement, respectively, when used with the GAT.

Arms & Interventions

Goldmann Applanation Tonometer

Active Comparator

Measurement of IOP with Goldmann Applanation Tonometer. All subjects will participate in this arm.

Intervention: IOP with Goldmann Applanation Tonometer (Device)

ORA G3 and ic100

Active Comparator

Measurement of IOP with Ocular Response Analyzer G3 and ic100 tonometers. All subjects will participate in this arm.

Intervention: IOP with comparator ORA G3 and ic100 tonometers (Device)

Tono-Vera Tonometer

Experimental

Measurement of IOP with Tono-Vera Tonometer. All subjects will participate in this arm.

Intervention: IOP with Tono-Vera Tonometer (Device)

Outcomes

Primary Outcomes

Demonstrate compliance with ANSI Z80.10-2014-Ophthalmics-Ophthalmic Instruments-Tonometers.

Time Frame: Through study completion, approximately 4 months.

Subjects will be distributed into Low IOP, Medium IOP, and High IOP groups based on Goldmann Applanation Tonometer measurements. The Tono-Vera Tonometer measurements will be within +/-5.0 mmHg of the Goldmann Applanation Tonometer measurements in all groups.

Secondary Outcomes

  • Data collection for two measurement modes.(Through study completion, approximately 4 months.)
  • Data collection for device calibration.(Through study completion, approximately 4 months.)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials